litlas
ログインアカウント作成

Keyur P. Patel

2010–2025 年に発表

167
論文数
20,110
被引用数
76
h 指数
163
i10 指数

被引用数

Keyur P. Patel の年別被引用数2001 年: 被引用 2 件2009 年: 被引用 1 件2010 年: 被引用 2 件2011 年: 被引用 4 件2012 年: 被引用 10 件2013 年: 被引用 15 件2014 年: 被引用 31 件2015 年: 被引用 81 件2016 年: 被引用 119 件2017 年: 被引用 168 件2018 年: 被引用 142 件2019 年: 被引用 610 件2020 年: 被引用 791 件2021 年: 被引用 907 件2022 年: 被引用 877 件2023 年: 被引用 924 件2024 年: 被引用 1,481 件2025 年: 被引用 704 件2026 年: 被引用 6 件2002〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,768 件、この内訳の 31.2%中国: 引用元論文 633 件、この内訳の 7.1%イタリア: 引用元論文 611 件、この内訳の 6.9%ドイツ: 引用元論文 540 件、この内訳の 6.1%イギリス: 引用元論文 490 件、この内訳の 5.5%フランス: 引用元論文 434 件、この内訳の 4.9%スペイン: 引用元論文 306 件、この内訳の 3.4%カナダ: 引用元論文 303 件、この内訳の 3.4%オーストラリア: 引用元論文 274 件、この内訳の 3.1%オランダ: 引用元論文 230 件、この内訳の 2.6%日本: 引用元論文 222 件、この内訳の 2.5%スイス: 引用元論文 157 件、この内訳の 1.8%
0%31.2%その他 21.5%

機関

分野

  • Medicine75.5%
  • Biochemistry, Genetics and Molecular Biology18.8%
  • Immunology and Microbiology2.8%
  • Environmental Science0.8%
  • Computer Science0.7%
  • Engineering0.6%
  • その他0.8%

トピック

  • Acute Myeloid Leukemia Research15.8%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment5.8%
  • Cancer Genomics and Diagnostics5.6%
  • Chronic Myeloid Leukemia Treatments5.2%
  • Acute Lymphoblastic Leukemia research4.3%
  • Chronic Lymphocytic Leukemia Research3.4%
  • その他59.9%

共著者

全論文

検索で開く
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

    著者: Joseph D. Khoury, Éric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio, Jane F. Apperley, Rafael Bejar, Emilio Berti, Lambert Busque, John K. C. Chan, Weina Chen, Xueyan Chen, Wee Joo Chng, John Choi, Isabel Colmenero, Sarah E. Coupland, Nicholas C.P. Cross, Daphne de Jong, M. Tarek Elghetany, Emiko Takahashi, Jean‐François Emile, Judith A. Ferry, Linda Fogelstrand, Michaëla Fontenay, Ulrich Germing, Sumeet Gujral, Torsten Haferlach, Claire Harrison, Jennelle C. Hodge, Shimin Hu, Joop H. Jansen, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiaoqiu Li, Megan S. Lim, Keith R. Loeb, Sanam Loghavi, Andrea N. Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William A. Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srđan Verstovšek, Wei Wang, Brent L. Wood, Wenbin Xiao, Cecilia C.S. Yeung, Andreas Hochhaus - Leukemia 2022 被引用: 3,904

  2. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

    著者: Courtney D. DiNardo, Ing Soo Tiong, Anna Quaglieri, Sarah MacRaild, Sanam Loghavi, Fiona C. Brown, Rachel Thijssen, Giovanna Pomilio, Adam Ivey, Jessica M. Salmon, Christina Glytsou, Shaun Fleming, Q. Zhang, Huaxian Ma, Keyur P. Patel, Steven M. Kornblau, Zhen Xu, Chong Chyn Chua, Xufeng Chen, Piers Blombery, Christoffer Flensburg, Nik Cummings, Iannis Aifantis, Hagop M. Kantarjian, David C.S. Huang, Andrew W. Roberts, Ian J. Majewski, Marina Konopleva, Andrew H. Wei - Blood 2020 被引用: 649

  3. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

    著者: Elias Jabbour, Nicholas J. Short, Nitin Jain, Xuelin Huang, Guillermo Montalban‐Bravo, Pinaki P. Banerjee, Katayoun Rezvani, Xianli Jiang, Kun Hee Kim, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, Keyur P. Patel, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia‐Manero, Ghayas C. Issa, Fadi Haddad, Monica Kwari, Jennifer Thankachan, Ricardo Delumpa, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian - The Lancet Haematology 2022 被引用: 239

  4. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

    著者: Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu, Prajwal Boddu, Mansour Alfayez, Jörge E. Cortes, Marina Konopleva, Farhad Ravandi‐Kashani, Elias Jabbour, Tapan M. Kadia, Graciela M. Nogueras‐González, Jing Ning, Naveen Pemmaraju, Courtney D. DiNardo, Michael Andreeff, Sherry Pierce, Tauna Gordon, Steven M. Kornblau, Wilmer Flores, Zainab Alhamal, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Keyur P. Patel, Jorge Blando, James P. Allison, Padmanee Sharma, Hagop M. Kantarjian - Cancer Discovery 2018 被引用: 571

  5. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

    著者: Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A. Wang, Yuanqing Yan, Ken Furudate, Jairo Matthews, Latasha Little, Curtis Gumbs, Jianhua Zhang, Xingzhi Song, Erika J. Thompson, Keyur P. Patel, Carlos E. Bueso‐Ramos, Courtney D. DiNardo, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Jörge E. Cortes, Kapil N. Bhalla, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Marina Konopleva, Daisuke Nakada, Nicholas E. Navin, Niko Beerenwinkel, P. Andrew Futreal, Koichi Takahashi - Nature Communications 2020 被引用: 387

  6. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    著者: Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, Courtney D. DiNardo, Lucy A. Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro M. Vannucchi, Keyur P. Patel, Daniel A. Arber, Maria E. Arcila, Rafael Bejar, Nancy Berliner, Michael J. Borowitz, Susan Branford, Anna Brown, Catherine Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia‐Manero, Torsten Haferlach, Eva Hellström‐Lindberg, Annette S. Kim, Jeffery M. Klco, Rami S. Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G. Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 被引用: 208

  7. Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML

    著者: Nicholas J. Short, Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Lewis Nasr, Walid Macaron, Musa Yılmaz, Gautam Borthakur, Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero, Ghayas C. Issa, Kelly S. Chien, Elias Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J. Stojanik, Keyur P. Patel, Regina Abramova, Jennifer Thankachan, Marina Konopleva, Hagop M. Kantarjian, Farhad Ravandi - Journal of Clinical Oncology 2024 被引用: 146

  8. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

    著者: Koichi Takahashi, Feng Wang, Hagop M. Kantarjian, Doss Denaha, Kanhav Khanna, Erika J. Thompson, Li Zhao, Keyur P. Patel, Sattva S. Neelapu, Curtis Gumbs, Carlos E. Bueso‐Ramos, Courtney D. DiNardo, Simona Colla, Farhad Ravandi, Jianhua Zhang, Xuelin Huang, Xifeng Wu, Felipe Samaniego, Guillermo Garcia‐Manero, P. Andrew Futreal - The Lancet Oncology 2016 被引用: 400

  9. Ibrutinib and Venetoclax for First-Line Treatment of CLL

    著者: Nitin Jain, Michael J. Keating, Philip A. Thompson, Alessandra Ferrajoli, Jan A. Burger, Gautam Borthakur, Koichi Takahashi, Zeev Estrov, Nathan Fowler, Tapan M. Kadia, Marina Konopleva, Yesid Alvarado, Musa Yılmaz, Courtney D. DiNardo, Prithviraj Bose, Maro Ohanian, Naveen Pemmaraju, Elias Jabbour, Koji Sasaki, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Jeffrey L. Jorgensen, Naveen Garg, Xuemei Wang, Katrina Sondermann, Nichole Cruz, Chongjuan Wei, Ana Ayala, William Plunkett, Hagop M. Kantarjian, Varsha Gandhi, William G. Wierda - New England Journal of Medicine 2019 被引用: 504

  10. High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse

    著者: Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Marina Konopleva, Nitin Jain, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Walid Macaron, Tapan M. Kadia, Sa A. Wang, Jeffrey L. Jorgensen, Joseph D. Khoury, Musa Yılmaz, Partow Kebriaei, Koichi Takahashi, Guillermo Garcia‐Manero, Naval Daver, Sean M. Post, Xuelin Huang, Steven M. Kornblau, S. Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Elias Jabbour - Blood Advances 2022 被引用: 112

  11. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults

    著者: Nitin Jain, Kathryn G. Roberts, Elias Jabbour, Keyur P. Patel, Agda Karina Eterovic, Ken Chen, Patrick A. Zweidler‐McKay, Xinyan Lu, Gloria L. Fawcett, Sa A. Wang, Sergej Konoplev, Richard C. Harvey, I‐Ming Chen, Debbie Payne-Turner, Marcus Valentine, Deborah A. Thomas, Guillermo Garcia‐Manero, Farhad Ravandi, Jörge E. Cortes, Steven M. Kornblau, Susan O’Brien, Sherry Pierce, Jeffrey L. Jorgensen, Kenna Shaw, Cheryl L. Willman, Charles G. Mullighan, Hagop M. Kantarjian, Marina Konopleva - Blood 2016 被引用: 386

  12. Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

    著者: Nicholas J. Short, Guillermo Montalban‐Bravo, Hyunsoo Hwang, Jing Ning, Miguel Franquiz, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Courtney D. DiNardo, Farhad Ravandi, Guillermo Garcia‐Manero, Koichi Takahashi, Marina Konopleva, Naval Daver, Ghayas C. Issa, Michael Andreeff, Hagop M. Kantarjian, Tapan M. Kadia - Blood Advances 2020 被引用: 181

  13. Ultrasensitive NGS MRD assessment in Ph+ ALL : Prognostic impact and correlation with RT‐PCR for BCR::ABL1

    著者: Nicholas J. Short, Elias Jabbour, Walid Macaron, Farhad Ravandi, Nitin Jain, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Sanam Loghavi, Fadi Haddad, Musa Yılmaz, Ghayas C. Issa, Partow Kebriaei, Steven M. Kornblau, Sarah Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Hagop M. Kantarjian - American Journal of Hematology 2023 被引用: 73

  14. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements

    著者: Ghayas C. Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas J. Short, Fadi Haddad, Zhenya Tang, Keyur P. Patel, Branko Cuglievan, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Guillermo Garcia‐Manero, Marina Konopleva, Michael Andreeff, Hagop M. Kantarjian, Farhad Ravandi - Blood Cancer Journal 2021 被引用: 99

  15. Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial

    著者: Elias Jabbour, Nicholas J. Short, Nitin Jain, Philip A. Thompson, Tapan M. Kadia, Alessandra Ferrajoli, Xuelin Huang, Musa Yılmaz, Yesid Alvarado, Keyur P. Patel, Guillermo Garcia‐Manero, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian - The Lancet Haematology 2022 被引用: 82

  16. Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia

    著者: Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas J. Short, Ghayas C. Issa, Abhishek Maiti, Hussein A. Abbas, Naval Daver, Naveen Pemmaraju, Sherry Pierce, Kelly S. Chien, Koji Sasaki, Tapan M. Kadia, Danielle Hammond, Gautam Borthakur, Keyur P. Patel, Farhad Ravandi, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Courtney D. DiNardo - Blood 2023 被引用: 61

  17. Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML

    著者: Courtney D. DiNardo, Farhad Ravandi, Sam Agresta, Marina Konopleva, Koichi Takahashi, Tapan M. Kadia, Mark J. Routbort, Keyur P. Patel, Mark Brandt, Sherry Pierce, Guillermo Garcia‐Manero, Jörge E. Cortes, Hagop M. Kantarjian - American Journal of Hematology 2015 被引用: 315

  18. Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

    著者: Feng Wang, Kiyomi Morita, Courtney D. DiNardo, Ken Furudate, Tomoyuki Tanaka, Yuanqing Yan, Keyur P. Patel, Kyle J. MacBeth, Bin Wu, Guowen Liu, Mark G. Frattini, Jairo Matthews, Latasha Little, Curtis Gumbs, Xingzhi Song, Jianhua Zhang, Erika J. Thompson, Tapan M. Kadia, Guillermo Garcia‐Manero, Elias Jabbour, Farhad Ravandi, Kapil N. Bhalla, Marina Konopleva, Hagop M. Kantarjian, P. Andrew Futreal, Koichi Takahashi - Nature Communications 2021 被引用: 115

  19. Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML

    著者: Ghayas C. Issa, Aram Bidikian, Sangeetha Venugopal, Marina Konopleva, Courtney D. DiNardo, Tapan M. Kadia, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Musa Yılmaz, Nicholas J. Short, Abhishek Maiti, Koji Sasaki, Lucia Masárová, Sherry Pierce, Koichi Takahashi, Guilin Tang, Sanam Loghavi, Keyur P. Patel, Michael Andreeff, Kapil N. Bhalla, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian, Naval Daver - Blood Advances 2022 被引用: 56

  20. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

    著者: Yasmin Abaza, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Elihu H. Estey, Gautam Borthakur, Elias Jabbour, Stefan Faderl, Susan O’Brien, William G. Wierda, Sherry Pierce, Mark Brandt, Deborah McCue, Rajyalakshmi Luthra, Keyur P. Patel, Steven M. Kornblau, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Nitin Jain, Srđan Verstovšek, Alessandra Ferrajoli, Michael Andreeff, Marina Konopleva, Zeev Estrov, Maria Cielo Foudray, David McCue, Jörge E. Cortes, Farhad Ravandi - Blood 2016 被引用: 297

  21. Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    著者: Nicholas J. Short, Elias Jabbour, Koji Sasaki, Keyur P. Patel, Susan O’Brien, Jörge E. Cortes, Rebecca Garris, Ghayas C. Issa, Guillermo Garcia‐Manero, Rajyalakshmi Luthra, Deborah A. Thomas, Hagop M. Kantarjian, Farhad Ravandi - Blood 2016 被引用: 253

  22. Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens

    著者: Curtis A. Lachowiez, Sanam Loghavi, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Kiran Naqvi, Yesid Alvarado, Musa Yılmaz, Nicholas J. Short, Maro Ohanian, Sherry R. Pierce, Keyur P. Patel, Wei Qiao, Jing Ning, Koji Sasaki, Koichi Takahashi, Elias Jabbour, Michael Andreeff, Farhad Ravandi, Hagop M. Kantarjian, Marina Konopleva, Courtney D. DiNardo - Blood Advances 2020 被引用: 156

  23. Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors

    著者: Ahmad S. Alotaibi, Musa Yılmaz, Rashmi Kanagal‐Shamanna, Sanam Loghavi, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Marina Konopleva, Sherry Pierce, Sa A. Wang, Guilin Tang, Veronica Guerra, Bachar Samra, Naveen Pemmaraju, Elias Jabbour, Nicholas J. Short, Ghayas C. Issa, Maro Ohanian, Guillermo Garcia‐Manero, Kapil N. Bhalla, Keyur P. Patel, Koichi Takahashi, Michael Andreeff, Jörge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi, Naval Daver - Blood Cancer Discovery 2020 被引用: 97

  24. Hypomethylating agent and venetoclax with FLT3 inhibitor “triplet” therapy in older/unfit patients with FLT3 mutated AML

    著者: Musa Yılmaz, Hagop M. Kantarjian, Nicholas J. Short, Patrick K. Reville, Marina Konopleva, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Naveen Pemmaraju, Abhishek Maiti, Elias Jabbour, Nitin Jain, Ghayas C. Issa, Koichi Takahashi, Koji Sasaki, Maro Ohanian, Sherry Pierce, Guilin Tang, Sanam Loghavi, Keyur P. Patel, Sa A. Wang, Guillermo Garcia‐Manero, Michael Andreeff, Farhad Ravandi, Naval Daver - Blood Cancer Journal 2022 被引用: 64